{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:10:09Z","timestamp":1773245409910,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education, Science, and Technology","doi-asserted-by":"publisher","award":["NRF-2017R1A2B4005136"],"award-info":[{"award-number":["NRF-2017R1A2B4005136"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cyto.2018.10.009","type":"journal-article","created":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T21:58:41Z","timestamp":1539467921000},"page":"371-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1499-7131","authenticated-orcid":false,"given":"Jun Ho","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Ju","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cyto.2018.10.009_b0005","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","article-title":"Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?","volume":"106","author":"Grogg","year":"2005","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cyto.2018.10.009_b0010","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1016\/j.ejca.2013.04.029","article-title":"A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial","volume":"49","author":"Morschhauser","year":"2013","journal-title":"Eur. J. Cancer (Oxford, England : 1990)"},{"key":"10.1016\/j.cyto.2018.10.009_b0015","doi-asserted-by":"crossref","unstructured":"A.J.M. Neha Mehta-Shah, Matthew Lunning, Peggy Lynch, Mark Scheuerman, Anita Kumar, John F Gerecitano, Andrew D Zelenetz, Paul A Hamlin Jr., Ariela Noy, Matthew J. Matasar, M. Lia Palomba, Anas Younes, Wendy Schaffer, Ravinder Grewal, Jurgen Rademaker, Craig S Sauter, Parastoo B. Dahi, Patricia Myskowski, Meenal Kheterpal, Ahmet Dogan, Melissa Pulitzer, Laura Tang, Ai Ni, and Steven M Horwitz, A Phase Ib\/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed\/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory T-Cell Lymphomas, Annual Meeting of American Society of Hematology, 2016.","DOI":"10.1182\/blood.V128.22.2991.2991"},{"issue":"8","key":"10.1016\/j.cyto.2018.10.009_b0020","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","article-title":"The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells","volume":"99","author":"Berger","year":"2002","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.cyto.2018.10.009_b0025","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2009-05-220111","article-title":"Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cyto.2018.10.009_b0030","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.10.009_b0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri2476","article-title":"GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation","volume":"9","author":"Ho","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.cyto.2018.10.009_b0040","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","article-title":"GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.cyto.2018.10.009_b0045","doi-asserted-by":"crossref","first-page":"65284","DOI":"10.18632\/oncotarget.11673","article-title":"GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2018.10.009_b0050","unstructured":"M.J.M. Mamta Gupta, Mary Stenson, Linda E. Wellik, Jing Jing Han, Andrew L. Feldman, Thomas M. Habermann, Thomas E. Witzig, In-Vivo Activation Of STAT3 In Angioimmunoblastic T Cell Lymphoma, PTCL Not Otherwise Specified, and ALK Negative Anaplastic Large Cell Lymphoma: Implications For Therapy, ASH Annual Meeting, 2013."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.009_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15384047.2017.1394538","article-title":"Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics","volume":"19","author":"Patel","year":"2018","journal-title":"Cancer Biol. Ther."},{"issue":"44","key":"10.1016\/j.cyto.2018.10.009_b0060","doi-asserted-by":"crossref","first-page":"76231","DOI":"10.18632\/oncotarget.19301","article-title":"Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma","volume":"8","author":"Ham","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2018.10.009_b0065","unstructured":"E. C Swerdlow SH, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein J. Thiele, J.W. Vardiman, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Lyon, France:, IARC Press, 2008."},{"issue":"27","key":"10.1016\/j.cyto.2018.10.009_b0070","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol. : Official J. Am. Soc. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2018.10.009_b0075","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood-2011-10-388538","article-title":"Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood"},{"issue":"45","key":"10.1016\/j.cyto.2018.10.009_b0080","doi-asserted-by":"crossref","first-page":"27158","DOI":"10.1074\/jbc.M115.682708","article-title":"Interleukin 10 (IL-10)-mediated Immunosuppression: March-I induction regulates antigen presentation by macrophages but not dendritic cells","volume":"290","author":"Mittal","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cyto.2018.10.009_b0085","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","article-title":"Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL","volume":"172","author":"He","year":"2004","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"issue":"1","key":"10.1016\/j.cyto.2018.10.009_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/2159-8290.CD-13-0276","article-title":"Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma","volume":"4","author":"Sangaletti","year":"2014","journal-title":"Cancer Discovery"},{"issue":"5","key":"10.1016\/j.cyto.2018.10.009_b0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/mp.51.5.273","article-title":"The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours","volume":"51","author":"Luciani","year":"1998","journal-title":"Molecular pathology : MP"},{"issue":"Suppl","key":"10.1016\/j.cyto.2018.10.009_b0100","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0092-8674(02)00701-8","article-title":"Cytokine signaling in 2002: new surprises in the Jak\/Stat pathway","volume":"109","author":"O'Shea","year":"2002","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cyto.2018.10.009_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-211046","article-title":"Regulatory role of the JAK STAT kinase signalling system on the IL-23\/IL-17 cytokine axis in psoriatic arthritis","volume":"76","author":"Raychaudhuri","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2018.10.009_b0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/bbrc.1999.1156","article-title":"Evidence for the involvement of JAK\/STAT pathway in the signaling mechanism of interleukin-17","volume":"262","author":"Subramaniam","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.cyto.2018.10.009_b0115","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-16-0224","article-title":"Dual faces of IFNgamma in cancer progression: a role of PD-L1 induction in the determination of pro- and antitumor immunity","volume":"22","author":"Mandai","year":"2016","journal-title":"Clin. Cancer Res. : Official J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.cyto.2018.10.009_b0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428199109107916","article-title":"Serum levels of interferon-gamma, cytotoxic factor and soluble Interleukin-2 receptor in childhood hemophagocytic syndromes","volume":"3","author":"Imashuku","year":"1991","journal-title":"Leukemia Lymphoma"},{"issue":"3","key":"10.1016\/j.cyto.2018.10.009_b0125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI115920","article-title":"Interleukin-7 is a growth factor for Sezary lymphoma cells","volume":"90","author":"Dalloul","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.cyto.2018.10.009_b0130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.1994.12.2.326","article-title":"Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sezary syndrome","volume":"12","author":"Foss","year":"1994","journal-title":"J. Clin. Oncol. : Official J. Am. Soc. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.cyto.2018.10.009_b0135","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1158\/0008-5472.CAN-10-3606","article-title":"IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias","volume":"71","author":"Silva","year":"2011","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cyto.2018.10.009_b0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.cyto.2018.10.009_b0145","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1073\/pnas.1003251107","article-title":"IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis","volume":"107","author":"Teng","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.cyto.2018.10.009_b0150","unstructured":"S.J.H.-D. Martin Bjerregaard Pedersen, Knud Bendix, Peter H. N\u00f8rgaard, M\u00f8ller Boe Michael, Mark Raffeld, Stefania Pittaluga, Torben Steiniche, Anke Bergmann, Inga Vater, Reiner Siebert, Wing-Chung Chan and Francesco d'Amore, Identification of a Subset of Peripheral T-Cell Lymphoma, Not Otherwise Specified, Characterized By FOXP3-Positive Regulatory T-Cell Phenotype, HTLV-1 Negativity and Poor Outcome, Annual Meeting of the American Society of Hematology, 2014."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:35Z","timestamp":1760907095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618303971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":30,"alternative-id":["S1043466618303971"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.10.009","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}